Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ANTITHYMOCYTE IMMUNOGLOBULIN for Aplastic anaemia: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where ANTITHYMOCYTE IMMUNOGLOBULIN was used for Aplastic anaemia.

Most Reported Side Effects for ANTITHYMOCYTE IMMUNOGLOBULIN

Side Effect Reports % Deaths Hosp.
Acute graft versus host disease 22 27.2% 9 0
Autoimmune haemolytic anaemia 12 14.8% 1 0
Acute lymphocytic leukaemia recurrent 10 12.4% 8 0
Chronic graft versus host disease 10 12.4% 3 0
Drug ineffective 10 12.4% 8 1
Graft versus host disease 10 12.4% 7 1
Therapeutic response decreased 10 12.4% 1 0
Thrombocytopenia 6 7.4% 2 0
Acute myeloid leukaemia recurrent 5 6.2% 5 0
Epstein-barr virus infection 5 6.2% 0 1
Post transplant lymphoproliferative disorder 5 6.2% 3 0

Other Indications for ANTITHYMOCYTE IMMUNOGLOBULIN

Prophylaxis against graft versus host disease (38) Stem cell transplant (12) Bone marrow conditioning regimen (8) Immunosuppression (5)

Other Drugs Used for Aplastic anaemia

CYCLOSPORINE (1,668) ELTROMBOPAG OLAMINE (1,617) ELTROMBOPAG (1,121) LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (421) EQUINE THYMOCYTE IMMUNE GLOBULIN (293) DEFERASIROX (277) THYMOCYTE IMMUNE GLOBULIN NOS (249) ROMIPLOSTIM (231) CYCLOPHOSPHAMIDE (122) METHYLPREDNISOLONE (90)

Related Pages

ANTITHYMOCYTE IMMUNOGLOBULIN Full Profile All Aplastic anaemia Drugs ANTITHYMOCYTE IMMUNOGLOBULIN Demographics ANTITHYMOCYTE IMMUNOGLOBULIN Timeline